AZ194
AZ194 is a first-in-class, orally active inhibitor of CRMP2-Ubc9 interaction and inhibitor of NaV1.7 (IC50=1.2 μM) . AZ194 blocks SUMOylation of CRMP2 to selectively reduce the amount of surface-expressed NaV1.7. Antinociceptive effects[1].
Product Specifications
CAS Number
2241651-99-8
UNSPSC
12352005
Hazard Statement
H315, H319
Target
Sodium Channel
Type
Reference compound
Related Pathways
Membrane Transporter/Ion Channel
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/az194.html
Purity
99.83
Solubility
DMSO : 33.33 mg/mL (ultrasonic)
Smiles
O=C(N1CCC(CC1)C2=NC3=C(N2CC4=CC(F)=CC=C4)C=CC=C3)C5=CC=C(C(OC)=C5)OCC6=CC(F)=CC=C6
Molecular Formula
C34H31F2N3O3
Molecular Weight
567.63
Precautions
H315, H319
References & Citations
[1]Cai S, et al. Selective targeting of NaV1.7 via inhibition of the CRMP2-Ubc9 interaction reduces pain in rodents. Sci Transl Med. 2021;13 (619) :eabh1314.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
Nav1.7
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS7145539 Inquire
Rabbit anti-Arabidopsis thaliana (Mouse-ear cress) SYT5 Polyclonal Antibody
Sign In for Pricing
View Details 
MBS2035449-01 0.1 mL
FITC-Linked Polyclonal Antibody to Factor Related Apoptosis (FAS)
Sign In for Pricing
View Details MBS2035449-02 0.2 mL
FITC-Linked Polyclonal Antibody to Factor Related Apoptosis (FAS)
Sign In for Pricing
View Details